JELLY BEANS GROUP Co., Ltd.
Notice of Conclusion of Exclusive Distribution Agreement for the “iHEAL” Brand in Japan
Entered into exclusive distribution agreement for the iHEAL brand in Japan. BIOLAB will manufacture and supply, AIDEN LAB JAPAN will handle import and marketing. Full-scale sales planned to commence in the second half of the fiscal year ending January 2027. The impact on the domestic market growth and on sales and profits to be analyzed going forward.
Key Figures
- Contract start date: Not disclosed
- Full-scale sales start: 2H FY2027 (year ending January 2027)
- Major shareholders & shareholding ratio: Not disclosed
AI要約
Overview of the Agreement
This agreement grants Jerry Beans Group exclusive rights in Japan for the sale and marketing of iHEAL brand products, with BIOLAB responsible for manufacturing and supply, and AIDEN LAB JAPAN handling import and distribution. Sales will be conducted through direct channels, wholesale, and online, aiming to develop and expand the Japanese market. Full-scale sales are planned to begin in the second half of the fiscal year ending January 2027.
Counterparty Overview and Relationship
AIDEN LAB JAPAN operates in Japan as a company engaged in importing, marketing, and brand development of apparel products. BIOLAB Corp. is a Korean fermentation and probiotic research and manufacturing company that markets the iHEAL brand. Financial information for both parties is not disclosed, and no mutual capital, personnel, or transactional relationships are reported.
Jerry Beans Group Co., Ltd.
Company overview · Stock price · Financial data · All IR
